Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · MAXCYTE, INC. (MXCT)

MaxCyte Raises 2026 Revenue Guidance to $34 Million on Preliminary Q3 Revenue

Positive Impact 4 of 5 guidance Written later

MaxCyte reported preliminary, unaudited third quarter 2026 core business revenue of approximately $8.1 million, up 26% from the third quarter of 2025, and raised its full-year 2026 revenue guidance to approximately $34 million from $30 million to $32 million. The company said the results are subject to change and not audited, but described third quarter and second half revenue as ahead of its expectations, driven by accelerated instrument purchasing from a large customer and a milestone from an SPL partner.

Key points

  • Preliminary Q3 2026 core business revenue of approximately $8.1 million, up 26% year over year; SPL Program-related revenue of more than $1.0 million, including $1.0 million in milestone revenue.
  • Full-year 2026 revenue guidance raised to approximately $34 million from $30 million to $32 million.
  • Core business revenue guidance raised to approximately $28 million from $25 million to $27 million; SPL Program-related guidance raised to approximately $6 million from approximately $5 million.
  • Results are unaudited and subject to change; full third quarter results and royalty revenue will be reported on November 10, 2026.

The filing

CompanyMAXCYTE, INC. (MXCT)
Form8-K, current report
Filed with the SECOct 14, 2026, 8:10 AM ET
Accession number0001104659-26-115745

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.